Status:
WITHDRAWN
Intravenous Lidocaine and Quality of Recovery After Cesarean Delivery
Lead Sponsor:
Northwestern University
Conditions:
Pregnancy
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
When given intravenously, the local anesthetic lidocaine has been shown to decrease the amount of pain medication patients require when recovering from several types of surgeries. Cesarean delivery is...
Detailed Description
Pain after Cesarean delivery is a common occurrence on the labor and delivery unit. The increased use of neuraxial anesthesia has allowed the administration of neuraxial opioids to help with postopera...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists Class II
- English speaking
- Scheduled Cesarean delivery
Exclusion
- Allergy to local anesthetics
- Chronic opioid use
- Greater than 2 prior cesarean deliveries
- Prior myomectomy
- Prior classical cesarean incision
- BMI greater than 40
- History of cardiac disease
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 15 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02257346
Start Date
November 1 2014
End Date
February 15 2015
Last Update
June 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NorthwesternUniversity
Chicago, Illinois, United States, 60611